IRADIMED CORP - Common Stock (IRMD)

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Common Stock
Shares outstanding
12,733,410
Total 13F shares
6,133,726
Share change
+349,783
Total reported value
$292,922,643
Price per share
$47.74
Number of holders
109
Value change
+$17,028,448
Number of buys
61
Number of sells
37

Institutional Holders of IRADIMED CORP - Common Stock (IRMD) as of Q2 2023

As of 30 Jun 2023, IRADIMED CORP - Common Stock (IRMD) was held by 109 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,133,726 shares. The largest 10 holders included Nine Ten Capital Management LLC, Soleus Capital Management, L.P., RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., VANGUARD GROUP INC, RK Capital Management, LLC, Bares Capital Management, Inc., Ranger Investment Management, L.P., Russell Investments Group, Ltd., and DIMENSIONAL FUND ADVISORS LP. This page lists 109 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.